These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8568380)

  • 1. [Emergency drug therapy of fulminant hepatitis].
    Tsubota A; Kumada H
    Nihon Naika Gakkai Zasshi; 1995 Nov; 84(11):1821-5. PubMed ID: 8568380
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of type C fulminant and subfulminant hepatitis--featuring antiviral and immunosuppressive treatment].
    Yoshiba M
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):549-56. PubMed ID: 7563822
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapy of hepatic encephalopathy. Modification of the plasma aminogram using amino acid infusions].
    Ferenci P; Funovics J; Wewalka F
    Chir Forum Exp Klin Forsch; 1978; (1978):183-9. PubMed ID: 110563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Branched-chain amino acids for parenteral feeding in hepatic failure].
    Kábrt J; Masek Z; Svacina S; Pacovský V; Kruf M; Koubková H
    Sb Lek; 1988 Jul; 90(7):206-12. PubMed ID: 3146806
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term treatment of portosystemic encephalopathy with oral branched-chain amino acids--a case report.
    Fukuda K; Yao H; Murai K; Ibayashi S; Fujishima M
    Fukuoka Igaku Zasshi; 1999 Dec; 90(12):464-9. PubMed ID: 10655667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy of hepatic encephalopathy. Changes in the cerebrospinal fluid concentration of catecholamine neurotransmitters, ammonia and amino acids in the course of an infusion treatment with branched-chain amino acids].
    Rössle M; Herz R; Lehmann G; Luft M; Gerok W
    Infusionsther Klin Ernahr; 1982 Oct; 9(5):256-8. PubMed ID: 7141673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parenteral branched-chain amino acids for hepatic encephalopathy. What is the grade of recommendation?
    Minicucci MF; Azevedo PS; Paiva SA
    Clin Nutr; 2011 Feb; 30(1):131; author reply 132. PubMed ID: 20719410
    [No Abstract]   [Full Text] [Related]  

  • 8. [Physiopathology and therapy of fulminant hepatitis].
    Sato S; Suzuki K; Takikawa Y
    Nihon Naika Gakkai Zasshi; 1999 Sep; 88(9):1783-8. PubMed ID: 10581764
    [No Abstract]   [Full Text] [Related]  

  • 9. [Recent advances in the treatment of decompensated liver cirrhosis].
    Moriwaki H; Kato M; Murase M; Muto Y
    Nihon Rinsho; 1994 Jan; 52(1):192-6. PubMed ID: 8114292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [High branched-chain amino acid formulations in hepatic encephalopathy].
    Muggia-Sulam M; Freund HR
    Harefuah; 1982 Feb; 102(4):144-6. PubMed ID: 6807784
    [No Abstract]   [Full Text] [Related]  

  • 11. [Short-term treatment of chronic recurrent hepatic encephalopathy with enteral administration of a mixture rich in branched-chain amino acids and energy].
    Guarnieri GF; Chiesa L; Toigo G; Pozzato G; Lucchesi A; Sasso F; Frezza M
    G Clin Med; 1984 Feb; 65(2):79-85. PubMed ID: 6427048
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effectiveness of combined plasma exchange treatment in fulminant viral hepatitis].
    Markus R; Baumgarten R; Fengler JD; Bartke D; Binus R; Fischer J; Kilger B; Miersch H
    Dtsch Z Verdau Stoffwechselkr; 1985; 45(5):197-204. PubMed ID: 4085389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Eck fistula syndrome].
    Fukasawa M; Futagawa S
    Ryoikibetsu Shokogun Shirizu; 1995; (7):220-5. PubMed ID: 8749458
    [No Abstract]   [Full Text] [Related]  

  • 14. [Chronic liver disease].
    Ueki A
    Ryoikibetsu Shokogun Shirizu; 2003; (40):197-200. PubMed ID: 14626100
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prediction, diagnosis and therapy of fulminant hepatitis].
    Muto Y; Murakami N; Sugihara J
    Nihon Naika Gakkai Zasshi; 1990 Aug; 79(8):1012-7. PubMed ID: 2230480
    [No Abstract]   [Full Text] [Related]  

  • 16. [Oral supplementation of branched-chain amino acids in patients with hepatic failure].
    Yoshida S; Kakegawa T; Mizote H
    Nihon Rinsho; 1991 Nov; 49 Suppl():204-7. PubMed ID: 1665871
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum amino acids in hepatic encephalopathy--effects of branched chain amino acid infusion on serum aminogram.
    Watanabe A; Takesue A; Higashi T; Nagashima N
    Acta Hepatogastroenterol (Stuttg); 1979 Oct; 26(5):346-57. PubMed ID: 525213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy of hepatic coma].
    Schomerus H
    Z Gastroenterol Verh; 1983 Apr; 18():75-81. PubMed ID: 6192612
    [No Abstract]   [Full Text] [Related]  

  • 19. [Parenteral amino acid integration in chronic hepatic encephalopathy in oral low-protein treatment].
    Ferro GF; Ferraris R; Ghezzo L; Manca A; Asnaghi G; Arnaudo A; Domeniconi D; Rossi R; Bonetti G
    Minerva Dietol Gastroenterol; 1986; 32(1):11-7. PubMed ID: 3085018
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapy of hepatic encephalopathy].
    Egberts EH
    Leber Magen Darm; 1987 Aug; 17(4):244, 247-62, 265-73. PubMed ID: 3312884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.